Science and Research

Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks

The systemic processes involved in the manifestation of life-threatening COVID-19 and in disease recovery are still incompletely understood, despite investigations focusing on the dysregulation of immune responses after SARS-CoV-2 infection. To define hallmarks of severe COVID-19 in acute disease (n = 58) and in disease recovery in convalescent patients (n = 28) from Hannover Medical School, we used flow cytometry and proteomics data with unsupervised clustering analyses. In our observational study, we combined analyses of immune cells and cytokine/chemokine networks with endothelial activation and injury. ICU patients displayed an altered immune signature with prolonged lymphopenia but the expansion of granulocytes and plasmablasts along with activated and terminally differentiated T and NK cells and high levels of SARS-CoV-2-specific antibodies. The core signature of seven plasma proteins revealed a highly inflammatory microenvironment in addition to endothelial injury in severe COVID-19. Changes within this signature were associated with either disease progression or recovery. In summary, our data suggest that besides a strong inflammatory response, severe COVID-19 is driven by endothelial activation and barrier disruption, whereby recovery depends on the regeneration of the endothelial integrity.

  • Ruhl, L.
  • Pink, I.
  • Kühne, J. F.
  • Beushausen, K.
  • Keil, J.
  • Christoph, S.
  • Sauer, A.
  • Boblitz, L.
  • Schmidt, J.
  • David, S.
  • Jäck, H. M.
  • Roth, E.
  • Cornberg, M.
  • Schulz, T. F.
  • Welte, T.
  • Höper, M. M.
  • Falk, C. S.
Publication details
DOI: 10.1038/s41392-021-00819-6
Journal: Signal Transduct Target Ther
Pages: 418 
Number: 1
Work Type: Original
Location: BREATH
Disease Area: PALI
Partner / Member: MHH
Access-Number: 34893580


chevron-down